Evidence map›Paper›PMID 16960125›Full record

ArticleAmerican journal of respiratory cell and molecular biology2007

Thyroid transcription factor in differentiating type II cells: regulation, isoforms, and target genes.

Venkatadri Kolla, Linda W Gonzales, John Gonzales, Ping Wang, Sreedevi Angampalli, Sheldon I Feinstein, Philip L Ballard

Open access · greenAbstract read
In one paragraph

Article in American journal of respiratory cell and molecular biology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
1.1field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 76 citations in OpenAlex.

  1. Article
  2. Article
  3. Biomedicines · 2024
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Transcriptional control of lung alveolar type 1 cell development and maintenance by NK homeobox 2-1.Proceedings of the National Academy of Sciences of the United States of America · 2019
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Venkatadri KollaDepartment of Pediatrics, Children's Hospital of Philadelphia, University of Pennsylvania School of Medicine, USA.
Linda W Gonzales
John Gonzales
Ping Wang
Sreedevi Angampalli
Sheldon I Feinstein
Philip L Ballard
Children's Hospital of Philadelphia · US

Funding

UPTAKE AND REUTILIZATION OF SURFACTANT COMPONENTSP01HL019737 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI FISHER, ARON B. · 1985 to 2013
$23.6M
TIE 1 &oxygen sensitive pulmonary vascular developmentP50HL056401 · NHLBI · CHILDRENS HOSPITAL OF PHILADELPHIA · PI BALLARD, PHILIP L. · 1996 to 2005
$11.0M
NHLBI NIH HHS HL-19737NHLBI NIH HHS HL-56401
6 · The paper itself

Abstract

Thyroid transcription factor-1 (TTF-1, product of the Nkx2.1 gene) is essential for branching morphogenesis of the lung and enhances expression of surfactant proteins by alveolar type II cells. We investigated expression of two TTF-1 mRNA transcripts, generated by alternative start sites and coding for 42- and 46-kD protein isoforms in the mouse, during hormone-induced differentiation of human fetal lung type II cells in culture. Transcript for 42-kD TTF-1 was 20-fold more abundant than TTF-1(46) mRNA by RT-PCR. Only 42-kD protein was detected in lung cells, and its content increased during in vivo development and in response to in vitro glucocorticoid plus cAMP treatment. To examine TTF-1 target proteins, recombinant, phosphorylated TTF-1(42) was expressed in nuclei of cells by adenovirus transduction. By microarray analysis, 14 genes were comparably induced by recombinant TTF-1 (rTTF-1) and hormone treatment, and 9 additional hormone-responsive genes, including surfactant proteins-A/B/C, were partially induced by rTTF-1. The most highly (approximately 10-fold) TTF-1-induced genes were DC-LAMP (LAMP3) and CEACAM6 with induction confirmed by Western analysis and immunostaining. Treatment of cells with hormones plus small inhibitory RNA directed toward TTF-1 reduced TTF-1 content by approximately 50% and inhibited hormone induction of the 23 genes induced by rTTF-1. In addition, knockdown of TTF-1 inhibited 72 of 274 other genes induced by hormones. We conclude that 42-kD TTF-1 is required for induction of a subset of regulated genes during type II cell differentiation.

Indexed as

Cell DifferentiationGene Expression Regulation8-Bromo Cyclic Adenosine MonophosphateAdenoviridaeAnimalsAntigens, CDCell Adhesion MoleculesDexamethasoneGestational AgeGPI-Linked ProteinsHeLa CellsHumansLysosomal Membrane ProteinsMiceNuclear ProteinsProtein Biosynthesis8-Bromo Cyclic Adenosine MonophosphateAntigens, CDCEACAM6 protein, humanCell Adhesion MoleculesDexamethasoneGPI-Linked ProteinsLysosomal Membrane ProteinsNKX2-1 protein, humanNkx2-1 protein, mouseNuclear ProteinsProtein IsoformsRecombinant ProteinsRNA, MessengerRNA, Small InterferingThyroid Nuclear Factor 1Transcription Factors

Identifiers

PMID16960125
PMCPMC1899316
OpenAlexW2072220643

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.